Cyclacel Pharmaceuticals (CYCC) Stock Price, News, Quotes-Moomoo

US Stock MarketDetailed Quotes

CYCC Cyclacel Pharmaceuticals

Watchlist

2.1220
-0.1280-5.69%

Close May 22 16:00 ET

2.1000
-0.0220-1.04%

Post 17:41 ET

3.11MMarket Cap-96P/E (TTM)

Full Hours

Trade Overview

Unit: --

Capital Trend

IntradayDayWeekMonth

No Data

News

Cyclacel Pharmaceuticals Inc (CYCC) Q1 2024 Earnings Call Transcript Highlights: Navigating ...
Yahoo FinanceMay 15 05:01 ET
Earnings Call Summary | Cyclacel Pharmaceuticals(CYCC.US) Q1 2024 Earnings Conference
The following is a summary of the Cyclacel Pharmaceuticals, Inc. (CYCC) Q1 2024 Earnings Call Transcript:Financial Performance:Cyclacel reported cash and cash equivalents of $9.9 million as of the end
moomoo AIMay 15 01:31 ET · Conference Call
Cyclacel Pharmaceuticals, Inc. (CYCC) Q1 2024 Earnings Call Transcript
Cyclacel Pharmaceuticals, Inc. (CYCC) Q1 2024 Earnings Call Transcript
Earnings Call TranscriptsMay 14 20:08 ET
10-Q: Quarterly report
SEC announcementMay 14 17:16 ET · Announcements
Express News | Cyclacel Pharmaceuticals Q1 EPS $(2.27) Beats $(4.74) Estimate, Sales $29.00K
BenzingaMay 14 16:24 ET
Earnings Flash (CYCC) CYCLACEL PHARMACEUTICALS Posts Q1 Revenue $29,000
04:06 PM EDT, 05/14/2024 (MT Newswires) -- Earnings Flash (CYCC) CYCLACEL PHARMACEUTICALS Posts Q1 Revenue $29,000
MT NewswiresMay 14 16:06 ET

Comments

Trytosaveabit

May 14 16:33

Let’s call that a earnings win!

$Cyclacel Pharmaceuticals(CYCC.US)$ Cyclacel Pharmaceuticals (NASDAQ:CYCC) reported quarterly losses of $(2.27) per share which beat the analyst consensus estimate of $(4.74) by 52.11 percent. This is a 67.8 percent increase over losses of $(7.05) per share from the same period last year. The company reported $29.00 thousand in sales this quarter.